Key result
HIV/HCV co-infected patients show high HCV clearance rates alongside identifiable targets to close treatment gaps.
Why the study?
Tracking HCV viremia in people with HIV and identifying reasons for non-treatment can inform HCV microelimination efforts.
High rates of HCV clearance were observed among HIV/HCV co-infected patients in San Francisco, with specific targets identified to address remaining treatment gaps.
Answers are grounded in this paper and cite their sources.
Supports scaling HCV treatment in HIV co-infected patients; leaves open whether identified targets close gaps in other settings.
Tracking hepatitis C virus (HCV) viremia in people with HIV and identifying reasons for non-treatment can inform HCV microelimination efforts. We analyzed a retrospective cohort of co-infected patients in San Francisco and found high rates of HCV clearance and identified targets for intervention to close treatment gaps.
No takes yet. Share an insight, caveat, or question.
Haser et al. (2026) studied this question. HIV/HCV co-infected patients in San Francisco exhibited high rates of HCV clearance, alongside identifiable targets for intervention to close remaining treatment gaps.
Synapse has enriched 10 related papers. Consider them for comparative context: